Cladis Investment Advisory LLC Sells 305 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Cladis Investment Advisory LLC lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.2% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 2,201 shares of the healthcare conglomerate’s stock after selling 305 shares during the period. Cladis Investment Advisory LLC’s holdings in UnitedHealth Group were worth $1,287,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Tealwood Asset Management Inc. bought a new position in UnitedHealth Group during the third quarter worth $2,905,000. Asset Planning Services Inc. LA ADV boosted its position in shares of UnitedHealth Group by 1.2% during the 3rd quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock valued at $7,288,000 after purchasing an additional 150 shares in the last quarter. Sequoia Financial Advisors LLC increased its holdings in UnitedHealth Group by 13.7% in the third quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock worth $14,603,000 after purchasing an additional 3,006 shares in the last quarter. Captrust Financial Advisors boosted its holdings in shares of UnitedHealth Group by 0.9% during the 3rd quarter. Captrust Financial Advisors now owns 210,464 shares of the healthcare conglomerate’s stock worth $123,054,000 after buying an additional 1,789 shares in the last quarter. Finally, Americana Partners LLC lifted its position in shares of UnitedHealth Group by 10.8% during the 3rd quarter. Americana Partners LLC now owns 20,377 shares of the healthcare conglomerate’s stock valued at $11,914,000 after acquiring an additional 1,984 shares during the period. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on UNH. Royal Bank of Canada dropped their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. HSBC lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. UBS Group reduced their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Bank of America dropped their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Finally, KeyCorp started coverage on UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 target price on the stock. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $618.26.

UnitedHealth Group Trading Up 0.3 %

NYSE:UNH opened at $610.20 on Monday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm’s 50 day moving average is $585.43 and its 200 day moving average is $556.65. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock has a market capitalization of $561.55 billion, a PE ratio of 39.75, a price-to-earnings-growth ratio of 1.79 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter last year, the firm posted $6.56 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.38%. UnitedHealth Group’s payout ratio is 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.